Rett syndrome: Disruption of epigenetic control of postnatal neurological functions

Human Molecular Genetics

Volumn 24, Issue R1, 2015, Pages R10-R16

  Pohodich, Amy E ^a,b   Zoghbi, Huda Y ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b Texas Children's Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHYL CPG BINDING PROTEIN 2; CHROMATIN; MECP2 PROTEIN, HUMAN;

AMINO ACID SEQUENCE; CELL FUNCTION; CELL MATURATION; CHROMATIN; CONNECTOME; DNA METHYLATION; ELECTROENCEPHALOGRAM; EPIGENETICS; GENE CONTROL; GENE DISRUPTION; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; NERVE CELL NETWORK; NERVE CELL PLASTICITY; NONHUMAN; PHENOTYPE; POSTNATAL CARE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RETT SYNDROME; REVIEW; BRAIN; CYTOLOGY; FEMALE; GENETIC EPIGENESIS; GENETICS; GROWTH, DEVELOPMENT AND AGING; MALE; MENTAL DISEASE; METABOLISM; NERVE CELL;

BRAIN; CHROMATIN; EPIGENESIS, GENETIC; FEMALE; HUMANS; MALE; METHYL-CPG-BINDING PROTEIN 2; NEURODEVELOPMENTAL DISORDERS; NEURONS; RETT SYNDROME; TRANSCRIPTION, GENETIC;

EID: 84942035052     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddv217     Document Type: Review

References (76)

1. Laurvick, C.L., de Klerk, N., Bower, C., Christodoulou, J., Ravine, D., Ellaway, C., Williamson, S. and Leonard, H. (2006) Rett syndrome in Australia: a review of the epidemiology. J. Pediatr., 148, 347-352.
2. Hagberg, B. (1985) Rett's syndrome: prevalence and impact on progressive severe mental retardation in girls. Acta Paediatr. Scand., 74, 405-408.
3. Amir, R.E., Van den Veyver, I.B., Wan, M., Tran, C.Q., Francke, U. and Zoghbi, H.Y. (1999) Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat. Genet., 23, 185-188.
4. Bienvenu, T., Carrié, A., de Roux, N., Vinet, M.C., Jonveaux, P., Couvert, P., Villard, L., Arzimanoglou, A., Beldjord, C., Fontes, M. et al. (2000) MECP2 mutations account for most cases of typical forms of Rett syndrome. Hum. Mol. Genet., 9, 1377-1384.
5. Schanen, N.C., Kurczynski, T.W., Brunelle, D., Woodcock, M.M., Dure, L.S. and Percy, A.K. (1998) Neonatal encephalopathy in two boys in families with recurrent Rett syndrome. J. Child Neurol., 13, 229-231.
6. Neul, J.L., Kaufmann, W.E., Glaze, D.G., Christodoulou, J., Clarke, A.J., Bahi-Buisson, N., Leonard, H., Bailey, M.E.S., Schanen, N.C., Zappella, M. et al. (2010) Rett syndrome: revised diagnostic criteria and nomenclature. Ann. Neurol., 68, 944-950.
7. Glaze, D.G. (2005) Neurophysiology of Rett syndrome. J. Child Neurol., 20, 740-746.
8. Orrico, A., Lam, C., Galli, L., Dotti, M.T., Hayek, G., Tong, S.F., Poon, P.M., Zappella, M., Federico, A. and Sorrentino, V. (2000) MECP2 mutation in male patients with non-specific X-linked mental retardation. FEBS Lett., 481, 285-288.
9. Imessaoudene, B., Bonnefont, J.P., Royer, G., Cormier-Daire, V., Lyonnet, S., Lyon, G., Munnich, A. and Amiel, J. (2001) MECP2 mutation in non-fatal, non-progressive encephalopathy in a male. J. Med. Genet., 38, 171-174.
10. Meloni, I., Bruttini, M., Longo, I., Mari, F., Rizzolio, F., D'Adamo, P., Denvriendt, K., Fryns, J.P., Toniolo, D. and Renieri, A. (2000) A mutation in the Rett syndrome gene, MECP2, causes X-linked mental retardation and progressive spasticity in males. Am. J. Hum. Genet., 67, 982-985.
11. Fabio, R.A., Colombo, B., Russo, S., Cogliati, F., Masciadri, M., Foglia, S., Antonietti, A. and Tavian, D. (2014) Recent insights into genotype-phenotype relationships in patients with Rett syndrome using a fine grain scale. Res. Dev. Disabil., 35, 2976-2986.
12. Urbanowicz, A., Downs, J., Girdler, S., Ciccone, N. and Leonard, H. (2015) Aspects of speech-language abilities are influenced by MECP2 mutation type in girls with Rett syndrome. Am. J. Med. Genet. A, 167, 354-362.
13. Neul, J., Fang, P., Barrish, J. and Lane, J. (2008) Specific mutations in methyl-CpG-binding protein 2 confer different severity in Rett syndrome. Neurology, 70, 1313-1321.
14. Cohen, D., Lazar, G., Couvert, P., Desportes, V., Lippe, D., Mazet, P. and Héron, D. (2002) MECP2 mutation in a boy with language disorder and schizophrenia. Am. J. Psychiatry, 159, 148-149.
15. Inui, K., Akagi, M., Ono, J., Tsukamoto, H., Shimono, K., Mano, T., Imai, K., Yamada, M., Muramatsu, T., Sakai, N. et al. (2001) Mutational analysis of MECP2 in Japanese patients with atypical Rett syndrome. Brain Dev., 23, 212-215.
16. Moog, U., Van Roozendaal, K., Smeets, E., Tserpelis, D., Devriendt, K., Van Buggenhout, G., Frijns, J.-P. and Schrander-Stumpel, C. (2006) MECP2 mutations are an infrequent cause of mental retardation associated with neurological problems in male patients. Brain Dev., 28, 305-310.
17. Winnepenninckx, B., Errijgers, V., Hayez-Delatte, F., Reyniers, E. and Frank Kooy, R. (2002) Identification of a family with nonspecific mental retardation (MRX79) with the A140V mutation in the MECP2 gene: is there a need for routine screening? Hum. Mutat., 20, 249-252.
18. Klauck, S.M., Lindsay, S., Beyer, K.S., Splitt, M., Burn, J. and Poustka, A. (2002) A mutation hot spot for nonspecific X-linked mental retardation in the MECP2 gene causes the PPM-X syndrome. Am. J. Hum. Genet., 70, 1034-1037.
19. Van Esch, H., Bauters, M., Ignatius, J., Jansen, M., Raynaud, M., Hollanders, K., Lugtenberg, D., Bienvenu, T., Jensen, L.R., Gecz, J. et al. (2005) Duplication of the MECP2 region is a frequent cause of severe mental retardation and progressive neurological symptoms in males. Am. J. Hum. Genet., 77, 442-453.
20. Ramocki, M.B., Tavyev, Y.J. and Peters, S.U. (2010) The MECP2 duplication syndrome. Am. J. Med. Genet. Part A, 152, 1079-1088.
21. Van Esch, H. (2012) MECP2 duplication syndrome. Mol. Syndromol., 2, 128-136.
22. Armstrong, D., Dunn, J.K., Antalffy, B. and Trivedi, R. (1995) Selective dendritic alterations in the cortex of Rett syndrome. J. Neuropathol. Exp. Neurol., 54, 195-201.
23. Bauman, M.L., Kemper, T.L. and Arin, D.M. (1995) Pervasive neuroanatomic abnormalities of the brain in three cases of Rett's syndrome. Neurology, 45, 1581-1586.
24. Guy, J., Hendrich, B., Holmes, M., Martin, J.E. and Bird, A. (2001) A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat. Genet., 27, 322-326.
25. Jentarra, G.M., Olfers, S.L., Rice, S.G., Srivastava, N., Homanics, G.E., Blue, M., Naidu, S. and Narayanan, V. (2010) Abnormalities of cell packing density and dendritic complexity in the MeCP2 A140 V mouse model of Rett syndrome/X-linked mental retardation. BMC Neurosci., 11, 19.
26. Zhou, Z., Hong, E.J., Cohen, S., Zhao, W.-N., Ho, H.-Y.H., Schmidt, L., Chen, W.G., Lin, Y., Savner, E., Griffith, E.C. et al. (2006) Brain-specific phosphorylation of MeCP2 regulates activity-dependent Bdnf transcription, dendritic growth, and spine maturation. Neuron, 52, 255-269.
27. Dani, V.S., Chang, Q., Maffei, A., Turrigiano, G.G., Jaenisch, R. and Nelson, S.B. (2005) Reduced cortical activity due to a shift in the balance between excitation and inhibition in a mouse model of Rett syndrome. Proc. Natl Acad. Sci., 102, 12560-12565.
28. Moretti, P., Levenson, J.M., Battaglia, F., Atkinson, R., Teague, R., Antalffy, B., Armstrong, D., Arancio, O., Sweatt, J.D. and Zoghbi, H.Y. (2006) Learning and memory and synaptic plasticity are impaired in a mouse model of Rett syndrome. J. Neurosci., 26, 319-327.
29. Shahbazian, M.D., Antalffy, B., Armstrong, D.L. and Zoghbi, H.Y. (2002) Insight into Rett syndrome: MeCP2 levels display tissueand cell-specific differences and correlate with neuronal maturation. Hum. Mol. Genet., 11, 115-124.
30. Kishi, N. and Macklis, J.D. (2004) MECP2 is progressively expressed in post-migratory neurons and is involved in neuronal maturation rather than cell fate decisions. Mol. Cell. Neurosci., 27, 306-321.
31. Song, C., Feodorova, Y., Guy, J., Peichl, L., Jost, K.L., Kimura, H., Cardoso, M.C., Bird, A., Leonhardt, H., Joffe, B. et al. (2014) DNA methylation reader MECP2: cell type-and differentiation stage-specific protein distribution. Epigenetics Chromatin, 7, 17.
32. Skene, P.J., Illingworth, R.S., Webb, S., Kerr, A.R.W., James, K.D., Turner, D.J., Andrews, R. and Bird, A.P. (2010) Neuronal MeCP2 is expressed at near histone-octamer levels and globally alters the chromatin state. Mol. Cell, 37, 457-468.
33. Santos, M., Silva-Fernandes, A., Oliveira, P., Sousa, N. and Maciel, P. (2007) Evidence for abnormal early development in a mouse model of Rett syndrome. Genes. Brain. Behav., 6, 277-286.
34. Samaco, R.C., McGraw, C.M., Ward, C.S., Sun, Y., Neul, J.L. and Zoghbi, H.Y. (2013) Female Mecp2(+/-) mice display robust behavioral deficits on two different genetic backgrounds providing a framework for pre-clinical studies. Hum. Mol. Genet., 22, 96-109.
35. Baker, S.A., Chen, L., Wilkins, A.D., Yu, P., Lichtarge, O. and Zoghbi, H.Y. (2013) An AT-hook domain in MeCP2 determines the clinical course of Rett syndrome and related disorders. Cell, 152, 984-996.
36. Heckman, L.D., Chahrour, M.H. and Zoghbi, H.Y. (2014) Rettcausing mutations reveal two domains critical for MeCP2 function and for toxicity in MECP2 duplication syndrome mice. eLife, 3, e02676.
37. Lyst, M.J., Ekiert, R., Ebert, D.H., Merusi, C., Nowak, J., Selfridge, J., Guy, J., Kastan, N.R., Robinson, N.D., de Lima Alves, F. et al. (2013) Rett syndrome mutations abolish the interaction of MeCP2 with the NCoR/SMRT co-repressor. Nat. Neurosci., 16, 898-902.
38. Lewis, J.D., Meehan, R.R., Henzel, W.J., Maurer-Fogy, I., Jeppesen, P., Klein, F. and Bird, A. (1992) Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA. Cell, 69, 905-914.
39. Mellén, M., Ayata, P., Dewell, S., Kriaucionis, S. and Heintz, N. (2012) MeCP2 binds to 5hmC enriched within active genes and accessible chromatin in the nervous system. Cell, 151, 1417-1430.
40. Guo, J.U., Su, Y., Shin, J.J.H., Li, H., Xie, B., Zhong, C., Hu, S., Le, T., Fan, G., Zhu, H. et al. (2014) Distribution, recognition and regulation of non-CpG methylation in the adult mammalian brain. Nat. Neurosci., 17, 215-222.
41. Szulwach, K.E., Li, X., Li, Y., Song, C.-X., Wu, H., Dai, Q., Irier, H., Upadhyay, A.K., Gearing, M., Levey, A.I. et al. (2011) 5-hmC-mediated epigenetic dynamics during postnatal neurodevelopment and aging. Nat. Neurosci., 14, 1607-1616.
42. Lister, R., Mukamel, E.A., Nery, J.R., Urich, M., Puddifoot, C.A., Johnson, N.D., Lucero, J., Huang, Y., Dwork, A.J., Schultz, M.D. et al. (2013) Global epigenomic reconfiguration during mammalian brain development. Science, 341, 1237905.
43. Jones, P.A. (2012) Functions ofDNAmethylation: islands, start sites, gene bodies and beyond. Nat. Rev. Genet., 13, 484-492.
44. Chugani, H.T. (1998) A critical period of brain development: Studies of cerebral glucose utilization with PET. Prev. Med., 27, 184-188.
45. Huttenlocher, P.R. and Dabholkar, A.S. (1997) Regional differences in synaptogenesis in human cerebral cortex. J. Comp. Neurol., 387, 167-178.
46. Gabel, H.W., Kinde, B., Stroud, H., Gilbert, C.S., Harmin, D.A., Kastan, N.R., Hemberg, M., Ebert, D.H. and Greenberg, M.E. (2015) Disruption of DNA-methylation-dependent long gene repression in Rett syndrome. Nature, 522, 89-93.
47. Chen, L., Chen, K., Lavery, L.A., Baker, S.A., Shaw, C.A., Li, W. and Zoghbi, H.Y. (2015) MeCP2 binds to non-CGmethylated DNA as neurons mature, influencing transcription and the timing of onset for Rett syndrome. Proc. Natl Acad. Sci., 112, 5509-5514.
48. McGraw, C.M., Samaco, R.C. and Zoghbi, H.Y. (2011) Adult neural function requires MeCP2. Science, 333, 186.
49. Cheval, H., Guy, J., Merusi, C., De Sousa, D., Selfridge, J. and Bird, A. (2012) Postnatal inactivation reveals enhanced requirement for MeCP2 at distinct age windows. Hum. Mol. Genet., 21, 3806-3814.
50. Nikitina, T., Shi, X., Ghosh, R.P., Horowitz-Scherer, R.A., Hansen, J.C. and Woodcock, C.L. (2007) Multiple modes of interaction between the methylated DNA binding protein MeCP2 and chromatin. Mol. Cell. Biol., 27, 864-877.
51. Nan, X., Hou, J., Maclean, A., Nasir, J., Lafuente, M.J., Shu, X., Kriaucionis, S. and Bird, A. (2007) Interaction between chromatin proteins MECP2 and ATRX is disrupted by mutations that cause inherited mental retardation. Proc. Natl Acad. Sci., 104, 2709-2714.
52. Christodoulou, J., Grimm, A., Maher, T. and Bennetts, B. (2003) Rett BASE: The IRSA MECP2 variation database-a new mutation database in evolution. Hum. Mutat., 21, 466-472.
53. Hansen, J.C., Ghosh, R.P. and Woodcock, C.L. (2010) Binding of the Rett syndrome protein, MeCP2, to methylated and unmethylated DNA and chromatin. IUBMB Life, 62, 732-738.
54. Casas-Delucchi, C.S., Becker, A., Bolius, J.J. and Cristina Cardoso, M. (2012) Targeted manipulation of heterochromatin rescues MeCP2 Rett mutants and re-establishes higher order chromatin organization. Nucl. Acids Res., 40, e176.
55. Samaco, R.C., Mandel-Brehm, C., Chao, H.-T., Ward, C.S., Fyffe-Maricich, S.L., Ren, J., Hyland, K., Thaller, C., Maricich, S.M., Humphreys, P. et al. (2009) Loss of MeCP2 in aminergic neurons causes cell-autonomous defects in neurotransmitter synthesis and specific behavioral abnormalities. Proc. Natl Acad. Sci., 106, 21966-21971.
56. Jellinger, K., Armstrong, D., Zoghbi, H.Y. and Percy, A.K. (1988) Neuropathology of Rett syndrome. Acta Neuropathol., 76, 142-158.
57. Yoshikawa, H., Kaga, M., Suzuki, H., Sakuragawa, N. and Arima, M. (1991) Giant somatosensory evoked potentials in the Rett syndrome. Brain Dev., 13, 36-39.
58. Guy, J., Gan, J., Selfridge, J., Cobb, S. and Bird, A. (2007) Reversal of neurological defects in a mouse model of Rett syndrome. Science, 315, 1143-1147.
59. Zhang, W., Peterson, M., Beyer, B., Frankel, W.N. and Zhang, Z. (2014) Loss of MeCP2 from forebrain excitatory neurons leads to cortical hyperexcitation and seizures. J. Neurosci., 34, 2754-2763.
60. McLeod, F., Ganley, R., Williams, L., Selfridge, J., Bird, A. and Cobb, S.R. (2013) Reduced seizure threshold and altered network oscillatory properties in a mouse model of Rett syndrome. Neuroscience, 231, 195-205.
61. Kline, D.D., Ogier, M., Kunze, D.L. and Katz, D.M. (2010) Exogenous brain-derived neurotrophic factor rescues synaptic dysfunction in Mecp2-null mice. J. Neurosci., 30, 5303-5310.
62. Kron, M., Howell, C.J., Adams, I.T., Ransbottom, M., Christian, D., Ogier, M. and Katz, D.M. (2012) Brain activity mapping in Mecp2 mutant mice reveals functional deficits in forebrain circuits, including key nodes in the default mode network, that are reversed with ketamine treatment. J. Neurosci., 32, 13860-13872.
63. Schmid, D.A., Yang, T., Ogier, M., Adams, I., Mirakhur, Y., Wang, Q., Massa, S.M., Longo, F.M. and Katz, D.M. (2012) A TrkB small molecule partial agonist rescues TrkB phosphorylation deficits and improves respiratory function in a mouse model of Rett syndrome. J. Neurosci., 32, 1803-1810.
64. Kron, M., Lang, M., Adams, I.T., Sceniak, M., Longo, F. and Katz, D.M. (2014) A BDNF loop-domain mimetic acutely reverses spontaneous apneas and respiratory abnormalities during behavioral arousal in a mouse model of Rett syndrome. Dis. Model. Mech., 7, 1047-1055.
65. Couvert, P., Bienvenu, T., Aquaviva, C., Poirier, K., Moraine, C., Gendrot, C., Verloes, A., Andrès, C., Le Fevre, A.C., Souville, I. et al. (2001) MECP2 is highly mutated in X-linked mental retardation. Hum. Mol. Genet., 10, 941-946.
66. Chen, R.Z., Akbarian, S., Tudor, M. and Jaenisch, R. (2001) Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nat. Genet., 27, 327-331.
67. Stearns, N.A., Schaevitz, L.R., Bowling, H., Nag, N., Berger, U.V. and Berger-Sweeney, J. (2007) Behavioral and anatomical abnormalities in Mecp2 mutant mice: a model for Rett syndrome. Neuroscience, 146, 907-921.
68. Pelka, G.J. (2006) Mecp2 deficiency is associated with learning and cognitive deficits and altered gene activity in the hippocampal region of mice. Brain, 129, 887-898.
69. Chao, H.-T., Chen, H., Samaco, R.C., Xue, M., Chahrour, M., Yoo, J., Neul, J.L., Gong, S., Lu, H.-C., Heintz, N. et al. (2010) Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes. Nature, 468, 263-269.
70. Asaka, Y., Jugloff, D.G.M., Zhang, L., Eubanks, J.H. and Fitzsimonds, R.M. (2006) Hippocampal synaptic plasticity is impaired in the Mecp2-null mouse model of Rett syndrome. Neurobiol. Dis., 21, 217-227.
71. Chao, H.-T., Zoghbi, H.Y. and Rosenmund, C. (2007) MeCP2 controls excitatory synaptic strength by regulating glutamatergic synapse number. Neuron, 56, 58-65.
72. Calfa, G., Li, W., Rutherford, J.M. and Pozzo-Miller, L. (2015) Excitation/inhibition imbalance and impaired synaptic inhibition in hippocampal area CA3 of Mecp2 knockout mice. Hippocampus, 25, 159-168.
73. Castro, J., Garcia, R.I., Kwok, S., Banerjee, A., Petravicz, J., Woodson, J., Mellios, N., Tropea, D. and Sur, M. (2014) Functional recovery with recombinant human IGF1 treatment in a mouse model of Rett Syndrome. Proc. Natl Acad. Sci., 111, 9941-9946.
74. Gogolla, N., Takesian, A.E., Feng, G., Fagiolini, M. and Hensch, T.K. (2014) Sensory integration in mouse insular cortex reflects GABA circuit maturation. Neuron, 83, 894-905.
75. He, L.J., Liu, N., Cheng, T.L., Chen, X.J., Li, Y.D., Shu, Y.S., Qiu, Z.L. and Zhang, X.H. (2014) Conditional deletion of Mecp2 in parvalbumin-expressingGABAergic cells results in the absence of critical period plasticity. Nat. Commun., 5, 5036.
76. Chahrour, M. and Zoghbi, H.Y. (2007) The story of Rett syndrome: from clinic to neurobiology. Neuron, 56, 422-437.